← SynDRA
JNJ-54175446
SynDRA canonical compound SYN0039258 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | P2RX7 |
|---|
| Mechanism of action | purinergic receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- P2RX7 ANTAGONIST
- P2X purinoceptor 7 antagonist
- purinergic receptor antagonist
Cross-references
Synonyms
- CWFVVQFVGMFTBD-SECBINFHSA-N
- UNII-32524GLF40
- 32524GLF40
- SCHEMBL16036477
- BDBM254266
- AKOS032947046
- AS-35269
- J3.655.327H
- US9464084, 158
- (R)-(2-chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-1H-[1,2,3]triazolo[4,5-c]pyridin-5(4H)-yl)methanone
- (r)-(2-chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-4-methyl-1,4,6,7-tetrahydro-5h-[1,2,3]triazolo[4,5-c]pyridin-5-yl)methanone
- Methanone, (2-chloro-3-(trifluoromethyl)phenyl)((4R)-1-(5-fluoro-2-py
- RefChem:150553
- MFCD31556312
- A1L0I
- C18H13ClF4N6O
- orb1707157
- SCHEMBL30900468
- SCHEMBL31347774
- TQR1090
- GLXC-22837
- EX-A6857
- DA-64656
- HY-117508
- CS-0066258
- T15622
- [2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridin-5-yl]methanone
Look up JNJ-54175446 in the interactive SynDRA portal →